CAS
1550053-02-5
Formulation
A solid
Purity
≥98%
MW
287,289083
Shipment
-20
Long Term Storage
-20
Shelf Life
1460
Description
An HDAC3 inhibitor (Ki = 29 µM); selective for HDAC3 over HDAC1 and HDAC2 (Kis = 6,300 and 5,100 nM, respectively; reduces cytokine-induced increases in apoptosis in rat INS-1E β cells at 10 µM; reduces plasma glucose levels in rats and increases plasma insulin levels in a rat model of type 2 diabetes at 5 mg/kg
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).